Cargando…
Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
OBJECTIVE: To determine the frequency of antiphospholipid antibodies (aPL) in patients with unexplained articular manifestations. MATERIAL AND METHODS: Three hundred thirteen patients suffering from arthritis or arthralgia without evident cause and 266 healthy blood donors (HBD) were included in the...
Autores principales: | Melayah, Sarra, Ghozzi, Mariem, Ghedira, Ibtissem, Mankaï, Amani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833978/ https://www.ncbi.nlm.nih.gov/pubmed/36514859 http://dx.doi.org/10.1002/jcla.24812 |
Ejemplares similares
-
Frequency of serological markers of rheumatoid arthritis in patients with IgA anti‐β2 glycoprotein I antibodies
por: Melayah, Sarra, et al.
Publicado: (2022) -
IgA is the predominant isotype of anti‐β2 glycoprotein I antibodies in rheumatoid arthritis
por: Melayah, Sarra, et al.
Publicado: (2020) -
Antiphospholipid antibodies in autoimmune thyroid diseases
por: Mankaï, Amani, et al.
Publicado: (2022) -
Frequency of auto‐antibodies of type 1 diabetes in adult patients with celiac disease
por: Ghozzi, Mariam, et al.
Publicado: (2021) -
Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19
por: Melayah, Sarra, et al.
Publicado: (2022)